B Cells

Studies on leukemias and other blood related malignancies is one of the most relevant investigational and medicinal applications of flow cytometry. In the bone marrow, normal blood cells undergo a progressive series of differentiation and branch off as myeloid, B and T cells. Hematological disorders can arise at any stage of the cell, while the differentiating cell will express a distinctive marker depending on the stage of differentiation.

We at Novus Biologicals have added several new products to our CD antibody database. The CD, or Cluster of Differential proteins are a family of type I transmembrane glycoproteins widely expressed in immune cell populations. These include B cells, thymocytes and peripheral T cells. Widely used as cell markers, a recent antibody study identified three CD proteins - CD44+, CD49fhi, and CD133hi – as new cell markers in an aggressive, but uncommon type of breast cancer.